Publication | Open Access
Assessing Lead Time of Selected Ovarian Cancer Biomarkers: A Nested Case–Control Study
199
Citations
52
References
2009
Year
Serum concentrations of CA125, HE4, and mesothelin may provide evidence of ovarian cancer 3 years before clinical diagnosis, but the likely lead time associated with these markers appears to be less than 1 year.
| Year | Citations | |
|---|---|---|
Page 1
Page 1